SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-11-050247
Filing Date
2011-09-22
Accepted
2011-09-22 17:15:41
Documents
1
Period of Report
2011-09-20

Document Format Files

Seq Description Document Type Size
1 INTERWEST/ EHRLICH PURCHASE rrd322433.html 4  
1 INTERWEST/ EHRLICH PURCHASE rrd322433.xml 4 5993
  Complete submission text file 0001181431-11-050247.txt   7520
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Issuer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTERWEST PARTNERS 2710 SAND HILL ROAD, 2ND FLOOR MENLO PARK CA 94025
Business Address
Ehrlich Christopher B (Reporting) CIK: 0001293973 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51967 | Film No.: 111103695